Literature DB >> 23352511

New imidazo[1,2-a]pyridines carrying active pharmacophores: synthesis and anticonvulsant studies.

Shrikanth Ulloora1, Ramakrishna Shabaraya, Syed Aamir, Airody Vasudeva Adhikari.   

Abstract

Five new series of imidazo[1,2-a]pyridines carrying biologically active pyrazoline (4a-e), cyanopyridone (5a, b), cyanopyridine (6a-f), 2-aminopyrimidine (7a-f) and pyrimidine-2-thione (8a-d) systems were designed and synthesized as prominent anticonvulsant agents. The target compounds were screened for their in vivo anticonvulsant activity following maximal electroshock (MES) and subcutaneous pentylene tetrazole (scPTZ) methods at a small test dose of 10 mg/kg. Further, Rotarod toxicity method was used to study the toxicity profile of selected compounds. Compounds 4b, 5a, 5b, 6a, 7e and 8d possessing 4-fluorophenyl substituent at 2nd position of imidazo[1,2-a]pyridine ring displayed potent anticonvulsant activity without displaying any toxicity. Enhanced activity profile was observed for new compounds in PTZ method over MES method.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23352511     DOI: 10.1016/j.bmcl.2012.12.035

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  2 in total

1.  Microwave assisted the short time clean synthesis of 1,3-diketones as building blocks in heterocyclic synthesis: a facile synthesis and antimicrobial evaluation of new dihydropyridine, 4H-pyrane, dihydropyridazine, pyrimidine and pyrazole derivatives.

Authors:  Mohamed Ahmed Mahmoud Abdel Reheim; Ibrahim Saad Abdel Hafiz; Hend Saad Eldin Abdel Rady
Journal:  Mol Divers       Date:  2021-01-05       Impact factor: 3.364

2.  Crystal Correlation Of Heterocyclic Imidazo[1,2-a]pyridine Analogues and Their Anticholinesterase Potential Evaluation.

Authors:  Huey Chong Kwong; C S Chidan Kumar; Siau Hui Mah; Yew Leng Mah; Tze Shyang Chia; Ching Kheng Quah; Gin Keat Lim; Siddegowda Chandraju
Journal:  Sci Rep       Date:  2019-01-30       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.